[1]
Muñoz-Cerón, J. et al. 2025. Low dose Galcanezumab for treating trigeminal autonomic cephalalgias: clinical observation from Colombia and Mexico on behalf of ASOLAC. Headache Medicine. 16, 1 (Mar. 2025), 65–70. DOI:https://doi.org/10.48208/HeadacheMed.2025.9.